Background: Bladder cancer is the most common malignancy affecting the urinary tract. It is the fourth most common cancer in men and the ninth most common in women worldwide. It is at least three times more common in males than females suggesting the role of sex hormones in initiation and progression of bladder cancer. The purpose of this study is to detect the immunohistochemical expression of (AR) and (ER β ) in urothelial carcinoma and correlate their expression with the known prognostic parameters of urothelial carcinoma to illustrate their prognostic role.
Introduction
BLADDER Cancer (BC) is the most common malignancy in the urinary tract and Urothelial Carcinoma (UC) is the predominant histological Correspondence to: Dr. Manar El-Nady, The Department of Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt type [1] . Urothelial carcinoma is responsible for death of 165000 persons annually worldwide according to the International Agency for Research on Cancer and the World Health Organization, with the highest mortality rates among Egyptian males [1] . It is more common in middle and old age [2] . Females presented with the disease at older age than males [3] . Urothelial carcinoma is the 4 th most common cancer in men and the 9 th in women worldwide [1] . In Gharbia government, bladder cancer ranks the 3 rd in both sexes being the 2nd in males and the 7th in females [4] . It is at least three times more common in men than women [1] . Excessive exposure to carcinogens, e.g. cigarette smoke and industrial chemicals, has been suggested to be a cause of higher incidence of bladder cancer in males [5] . Even, after controlling these carcinogens, men still have a higher risk than women [6] .
In the light of the previous facts, existence of a relationship between sex hormones and cancer bladder is suggested. Data from animal and human studies suggested that sex hormones have important physiological effects on the lower urinary tract [7] . Sex steroids act by binding to their receptors in target cells including Androgen Receptors (ARs) and Estrogen Receptors (ERs) [8] . These receptors have been detected in normal bladder urothelium [9] . The AR and ER signaling pathways affect bladder cancer development and progression [8] . Bladder cancer management has remained essentially unchanged, with no new effective treatment options approved in the past few decades [10] . Treatment of non-muscle invasive bladder cancer involves transurethral resection of the tumour followed by intravesical chemo-or immunotherapy but muscleinvasive cancer requires radical cystectomy and systemic chemotherapy [11] . Many patients receiving BCG develop either local or systemic side 305 effects [10] . The effects of sex hormones on bladder cancer cells need to be studied, which might help in development of prognostic biomarkers and new therapies.
Material and Methods
This study was carried out on 70 cases of urothelial carcinoma of the urinary bladder (56 males and 14 females, age ranged between 28 and 88 years). These cases were collected retrospectively from the archives of Pathology Department, Faculty of Medicine, Tanta University and from some private laboratories during the period of the research from 2015 to 2017 and patients' data were obtained from files of surgery and oncology reports. Approval from Research Ethics Committee (REC), Faculty of Medicine, Tanta University, was taken antecedent to conducting study. Tissue specimens were in the form of radical cystectomy (15 specimens) and Transurethral Resection of the Tumour (TURT) (55 specimens). After histopathological evaluation, tumors were graded according to the WHO 2016 of urothelial neoplasia, and they were classified as low grade and high grade urothelial carcinoma. Tumors were staged according to American Joint Committee (AJCC), TNM pathologic staging of urinary bladder. Immunohistochemical staining was performed on 10% formalin fixed, paraffin embedded tissue blocks for evaluation of AR and ERR expression. Sections were immunohistochemically labeled, using primary antibodies to AR (EPR3778 clone, rabbit monoclonal antibody, 0.1ml, dilution 1:50; Dako, Egypt) and ER R (AR441 clone, mouse monoclonal antibody, 0.1 ]ml, dilution 1:300; Abcam, Egypt). AR and ER R staining was detected as brownish nuclear staining and all these stains were manually scored by the German Immunoreactive Score based on multiplying percentage of immunoreactive cells {0%=(0), 1-10%=(+1), 11-50%=(+2), 51-80%=(+3), 81-100%=(+4)} by staining intensity {Negative (+0), weak (+1), moderate (+2), strong (+3)}. Scores (range 0-12) were considered negative (0; 0-1), weakly positive (+1; 2-4), moderately positive (+2; 6-8) and strongly positive (+3; 9-12) [8] . Chi-square test and Spearman's correlation coefficient test were used as tests of significance to evaluate the association between categorized variables and p-value <0.05 was considered statistically significant.
Results
Different clinicopathological criteria of 70 bladder specimens were evaluated (Table 1) , then correlated with AR and ER R expression ( Table 2) . AR expression was not significantly correlated with the number of urinary bladder masses ( p-value=0.497). AR expression was significantly correlated to tumour grade ( p-value=0.026). AR expression was higher in low grade cases (78.5%) Fig. (1A) than high-grade cases (52.4%) Fig. (1B) .
AR expression was significantly correlated with degree of muscle invasion ( p-value=0.026) with higher AR expression in NMI tumours (pTa, pT1) (74.4%) opposite to only 48.4% of MI (pT2, pT3, pT4). In cystectomy specimens, there was a significant association between AR expression and the level of invasion (p-value=0.046) with negative correlation coefficient (r s) denoting loss of AR expression in more invasive tumours. AR expression wasn't significantly correlated with lymph node metastasis in cystectomy specimens and lesions with concomitant CIS (p-value=0.679, 0.703 respectively). There was a significant corre-
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lation between AR expression and perineural invasion (p-value=0.049). AR expression wasn't significantly correlated with lympho-vascular invasion (p-value=0.115). In the three cases that showed recurrence after treatment with TUR followed by intravesical BCG instillation, two primary cases (66.7%) were AR negative and one case (33.3%) was AR+2.
ER R expression was positive in 37 cases (52.9%) (11 weak, 20 moderate, 6 strong). ER R expression wasn't significantly correlated with the age and gender (p-value=0.592, 0.119 respectively). ERR expression was significantly correlated with tumor size and multiplicity (p-value=0.018, 0.016 respectively). ERR expression was significantly correlated to the tumour grade in the studied cases (p-value=0.005). Higher positive ER R in highgrade cases (66.7%) than low-grade cases (32.1%) Fig. (2A,B) .
ERR expression was significantly correlated with degree of muscle invasion (p-value=0.007) with lower ERR expression in NMI tumours (38.5%) opposite to 71% of MI Fig. (3A) . In cystectomy specimens, there was a significant association between ERR expression and invasion level (p-value=0.033) with positive correlation coefficient (r s ) denoting high ERR expression in more invasive tumours. In cystectomy specimens with lymph node metastasis, three cases (75%) showed positive expression, but it did not reach the statistically significant level (p-value=0.929) Fig. (3B) .
Lesions with concomitant CIS showed no significant correlation with ERR expression (p-value= 0.175). ERR expression was significantly correlated with perineural and lympho-vascular invasion (p-value=0.033, 0.041 respectively). The three cases (100%) that showed recurrence after treatment were ERR positive, but it did not reach the statistically significant level (p-value=0.279). 
Discussion
AR and ER β are members of nuclear receptor superfamily [3] . Androgen/androgen receptor signaling pathway up-regulates the expression of active β -catenin also affects p53 tumor suppressor functions [12] . A retrospective study involving patients who received androgen deprivation therapy for prostate cancer showed a significantly lower incidence of subsequent BC [13] . Higher AR expression associated with low grade tumour, nonmuscle invasive tumour, size less than 3cm and absent perineural invasion. Loss of AR expression was reported in cases with lymph node metastasis and risk of recurrence, but it did not reach the statistically significant level. From that, higher AR expression was associated with better prognosis of urothelial carcinoma which was in agreement with some studies [8, 14, 15] . In contrast to a study reported that AR expression had no prognostic value (124) and another one reported bad prognosis in AR-positive patients with higher rate of invasion, metastasis and recurrence [17] . High AR expression was significantly correlated with low-grade cases (p-value=0.026) which was in agreement with Miyamoto, et al., (p-value=0.023) [8] . In contrast, Mashhadi, et al., reported a significant association between AR expression and high-grade tumors (p-value=0.024) [17] . High AR expression was significantly correlated with NMI cases (p-value=0.026) which was in agreement with Miyamoto, et al. (2012) (p-value=0.018) [8] . In contrast to Mir, et al. (2011) who concluded loss of AR expression in NMI tumours (p-value= 0.048) [16] . ER β is the dominant estrogen receptors expressed in urothelium [10] . Estrogen affects cell cycle progression through up-regulation of both cyclin D1 and cyclin E [18] .
Higher ER β expression in the current study was significantly correlated with high grade tumours, more invasive tumours, size more than 3cm, multiple lesions in the urinary bladder, tumours with perineural and lympho-vascular invasion. High ER β expression was detected in cases with lymph node metastasis and risk of recurrence, but it did not reach the statistically significant level. From that, high ER β expression was associated with bad prognosis of urothelial carcinoma which was in agreement with most studies [8, 19] . In contrast Bangmin, et al., [20] reported favorable prognosis in ER β positive patients. High ER β expression was significantly correlated with high-grade tumours (p-value=0.005) which was in agreement with Miyamoto, et al. (2012) (p-value <0.001) [8] . In contrast, Bangmin, et al., reported a significant association between ER β expression and low-grade tumors (p-value=0.037) [20] . High ER β expression was significantly correlated with MI cases ( p-value=0.007) which was in agreement with Miyamoto, et al. (2012) (p-value <0.001) [8] . In contrast to Kontos, et al., who reported higher positive ER expression in NMI tumours (p-value=0.001) with good prognosis [21] .
